Entity Details

Primary name CYP21A2
Entity type gene
Source Source Link

Details

PrimaryID1589
RefseqGeneNG_007941
SymbolCYP21A2
Namecytochrome P450 family 21 subfamily A member 2
Chromosome6
Location6p21.33
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1999-09-17
ModificationDate2021-06-19

Ontological Relatives

UniProt IDsCP21A_HUMAN

GO terms

Show/Hide Table
GOName
GO:0004509 steroid 21-monooxygenase activity
GO:0005496 steroid binding
GO:0005506 iron ion binding
GO:0005789 endoplasmic reticulum membrane
GO:0006694 steroid biosynthetic process
GO:0006704 glucocorticoid biosynthetic process
GO:0006705 mineralocorticoid biosynthetic process
GO:0008202 steroid metabolic process
GO:0008395 steroid hydroxylase activity
GO:0016125 sterol metabolic process
GO:0020037 heme binding
GO:0103069 17-hydroxyprogesterone 21-hydroxylase activity
GO:0106309 progesterone 21-hydroxylase activity

Diseases

Show/Hide Table
Disease IDSourceNameDescription
201910 OMIMAdrenal hyperplasia 3 (AH3)A form of congenital adrenal hyperplasia, a common recessive disease due to defective synthesis of cortisol. Congenital adrenal hyperplasia is characterized by androgen excess leading to ambiguous genitalia in affected females, rapid somatic growth during childhood in both sexes with premature closure of the epiphyses and short adult stature. Four clinical types: 'salt wasting' (SW, the most severe type), 'simple virilizing' (SV, less severely affected patients), with normal aldosterone biosynthesis, 'non-classic form' or late-onset (NC or LOAH) and 'cryptic' (asymptomatic). The disease is caused by variants affecting the gene represented in this entry.